Astrazeneca Pharma India rose 1.34% to Rs 1,153 at 10:21 IST on BSE after the company reported net profit of Rs 3.22 crore in Q4 March 2018 as against net loss of Rs 9.56 crore in Q3 March 2017.
The result was announced after market hours yesterday, 21 May 2018.Meanwhile, the S&P BSE Sensex was up 87.07 points, or 0.25% to 34,703.20.
On the BSE, 2,418 shares were traded in the counter so far compared with average daily volumes of 6,049 shares in the past two weeks. The stock had hit a high of Rs 1,203.65 and a low of Rs 1,150 so far during the day. The stock hit a 52-week high of Rs 1,278 on 7 November 2017. The stock hit a 52-week low of Rs 882.55 on 22 August 2017.
Net sales rose 30.27% to Rs 150.73 crore in Q4 March 2018 over Q4 March 2017.
AstraZeneca Pharma India is the operating company covering manufacturing, sales and marketing activities. It has an innovative portfolio to address the unmet needs in non-communicable diseases such as diabetes, heart disease, cancer, asthma & COPD.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
